Benefit assessment of the medical device

Client situation

Our client, with its global headquarters in Germany, had developed an innovative medical device with the risk class III. The medical device was used for inpatient and outpatient treatment. Within the scope of the global market launch, the client had to undergo a large number of HTA procedures in various countries in order to obtain reimbursement

Our solution

We supported our client in the global HTA process by preparing the clinical evidence for the product according to country-specific requirements. Many synergy effects arose during this process. A large number of studies were available on the client's product, including an RCT, which facilitated the benefit assessment.

Client benefits

Thanks to our assistance, the client was able to obtain reimbursement in a large number of countries, with a corresponding positive effect on sales.